Evidence map›Paper›PMID 10811914›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse.

Q S Mi, L Zhou, D H Schulze, R T Fischer, A Lustig, L J Rezanka, D M Donovan, D L Longo, J J Kenny

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. A Single Human VCell reports · 2020
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Defining Natural Antibodies.Frontiers in immunology · 2017
    Article
  16. A Role for the Transcription FactorFrontiers in immunology · 2017
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Q S MiLaboratory of Immunology, B Cell Development Section, Gerontology Research Center, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA.
L Zhou
D H Schulze
R T Fischer
A Lustig
L J Rezanka
D M Donovan
D L Longo
J J Kenny
University of Maryland, Baltimore · US

Funding

Shaping The Preimmune B Cell RepertoireZIAAG000164 · NIA · NATIONAL INSTITUTE ON AGING · PI EVANS, MICHELE K · 2009 to 2010
$545k
Shaping The Preimmune B Cell RepertoireZ01AG000164 · NIA · NATIONAL INSTITUTE ON AGING · PI LONGO, DAN L. · 2002 to 2008
$462k
6 · The paper itself

Abstract

Phosphocholine (PC) is the immunodominant epitope found on the surface of Streptococcus pneumoniae (SPn). T15-idiotype Abs, whose heavy (H) chain variable region is encoded by the V1 gene, are dominant in the anti-PC response in adult mice and protect mice from lethal pneumococcal infection. The ability of anti-PC Abs using H chains other than the V1 H chain to protect against pneumococcal infection remains controversial. We generated V1(-/-) knockout mice to determine whether protective anti-PC Abs could be produced in the absence of the V1 gene. No anti-PC Abs were produced in V1(-/-) mice immunized with avirulent SPn; however, PC-BSA binding Abs were induced after immunization with PC-keyhole limpet hemocyanin but at significantly lower levels than those in wild-type mice. These Abs provided poor protection against virulent SPn; thus, <25% of V1(-/-) mice survived challenge with 10(4) bacteria as compared with 100% survival of V1(+/+) mice. The anti-PC Abs in V1(-/-) mice were heteroclitic, binding to nitrophenyl-PC better than to PC. None of nine hybridomas produced from V1(-/-) mice provided passive protection. However, the V1(-/-) mice produced normal amounts of Ab to SPn proteins that can partially protect mice against SPn. These data indicate that the V1 gene is critical for the production of anti-PC Abs providing optimum protection against infection with SPn, and the V1(-/-) mice could be useful in unmasking epitopes other than the immunodominant PC epitope on SPn capable of providing cross protection.

Indexed as

Gene DeletionGenes, ImmunoglobulinAnimalsAntibodies, BacterialAntibodies, MonoclonalAntigens, BacterialBacterial VaccinesCross ReactionsHemocyaninsHybridomasImmunity, InnateImmunodominant EpitopesImmunoglobulin Heavy ChainsMiceMice, KnockoutPhosphorylcholineAntibodies, BacterialAntibodies, MonoclonalAntigens, BacterialBacterial VaccinesHemocyaninsImmunodominant EpitopesImmunoglobulin Heavy Chainskeyhole-limpet hemocyaninPhosphorylcholine

Identifiers

PMID10811914
PMCPMC18553
OpenAlexW2023820319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.